AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2022
Mar 31, 2022
35006_dirs_2022-03-30_cd2159f3-8754-4a14-873d-dd40b8ef0ba1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2022-03-28
Reporting Person: Chao Jennifer M (N/A)
More from Edesa Biotech, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2